Terrie Curran
2020
In 2020, Terrie Curran earned a total compensation of $4.6M as President and Chief Executive Officer at Phathom Pharmaceuticals, a 34% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $356,875 |
|---|---|
| Option Awards | $3,285,608 |
| Salary | $498,940 |
| Stock Awards | $483,000 |
| Other | $10,031 |
| Total | $4,634,454 |
Curran received $3.3M in option awards, accounting for 71% of the total pay in 2020.
Curran also received $356.9K in non-equity incentive plan, $498.9K in salary, $483K in stock awards and $10K in other compensation.
Rankings
In 2020, Terrie Curran's compensation ranked 2,416th out of 13,090 executives tracked by ExecPay. In other words, Curran earned more than 81.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,416 out of 13,090 | 82nd |
Division Manufacturing | 923 out of 5,624 | 84th |
Major group Chemicals And Allied Products | 327 out of 2,257 | 86th |
Industry group Drugs | 278 out of 1,957 | 86th |
Industry Pharmaceutical Preparations | 200 out of 1,462 | 86th |
Source: SEC filing on April 6, 2021.
Curran's colleagues
We found two more compensation records of executives who worked with Terrie Curran at Phathom Pharmaceuticals in 2020.
News
Phathom Pharmaceuticals CEO Terrie Curran's 2023 pay falls 32% to $3.4M
April 12, 2024
Phathom Pharmaceuticals CEO Terrie Curran's 2022 pay slips 20% to $5M
April 13, 2023
Phathom Pharmaceuticals CEO Terrie Curran's 2020 pay jumps 34% to $4.6M
April 6, 2021
Phathom Pharmaceuticals CEO Terrie Curran receives $3.5M in 2019
April 8, 2020